Hippo Pathway in Cancer, towards the Realization of Hippo-Targeted Therapy
Author:
Open Access
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- WIP-YAP/TAZ as A New Pro-Oncogenic Pathway in GliomaCancers, 2018
- Toward the Discovery of a Novel Class of YAP–TEAD Interaction Inhibitors by Virtual Screening Approach Targeting YAP–TEAD Protein–Protein InterfaceCancers, 2018
- YAP and TAZ in Lung Cancer: Oncogenic Role and Clinical TargetingCancers, 2018
- Ubiquitin-Dependent Regulation of the Mammalian Hippo Pathway: Therapeutic Implications for CancerCancers, 2018
- The Hippo-YAP Pathway Regulates 3D Organ Formation and HomeostasisCancers, 2018
- YAP/TAZ Activation as a Target for Treating Metastatic CancerCancers, 2018
- The Hippo Pathway: Immunity and CancerCancers, 2018
- Targeting the Hippo Pathway Is a New Potential Therapeutic Modality for Malignant MesotheliomaCancers, 2018
- Targeting the Hippo Pathway and Cancer through the TEAD Family of Transcription FactorsCancers, 2018
- Linking Extracellular Matrix Agrin to the Hippo Pathway in Liver Cancer and BeyondCancers, 2018